Branislav Ilic

5PUBLICATIONS
26CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 15, 2026
Association of PDGFRB, VEGFR2, and TGFB1 Gene Polymorphisms with Nintedanib Efficacy and Adverse Effects in Patients with Progressive Pulmonary Fibrosis.

|Jan 28, 2026
Comparison of the Efficacy of Pirfenidone and Nintedanib in the Treatment of Patients with Idiopathic Pulmonary Fibrosis-A Single-Center Experience.

Nikola Trboljevac, Sanja Dimic-Janjic, Milica Kontic

|Sep 27, 2025
Real World Data on the Efficacy of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer: A Single-Center Experience.

Vesna Ćeriman Krstić, Natalija Samardžić, Mihailo Stjepanović

|Apr 29, 2025
Efficacy of Durvalumab Consolidation Therapy After Sequential Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer-Experience from the Daily Hospital of Clinic for Pulmonology, University Clinical Center of Serbia.

Vesna Ćeriman Krstić, Natalija Samardžić, Spasoje Popević

|Mar 28, 2025
Hyperglycemia and Lung Cancer-A Possible Relationship.

Spasoje Popevic, Nikola Maric, Branislav Ilic

Pageof 1

Frequent Collaborators

4 joint publications

Mihailo Stjepanovic

3 joint publications

Spasoje Popevic

3 joint publications

Sanja Dimic-Janjic

3 joint publications

Nikola Čolić